Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK2375 (Entinostat) + Exemestane in Advanced/Recurrent Breast Cancer
NCT03291886Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Sep 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in breast cancer, sponsored by Kyowa Kirin. Started Sep 2017; status: completed.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03291886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291886.